ThinkSabio

$RCUS

$17.85▲ -1.8% YTD

12 SEC 13D/G filings tracked · Last updated Nov 2, 2026

Filing History
News
RCUS ▼ -1.8% - Arcus Biosciences, Inc.
CP $17.85▲ -1.8%Nov 2, 2026 · ThinkSabio Blog

$RCUS - Arcus Biosciences to Participate in the Jefferies Global Healthcare Conference 2026 in London…

News
RCUS ▼ -4.1% - Arcus Biosciences, Inc.
CP $17.76▲ -4.1%Oct 26, 2026 · ThinkSabio Blog

$RCUS - Arcus Biosciences Announces New Employment Inducement Grants…

News
RCUS ▼ -6.3% - Arcus Biosciences, Inc.
CP $17.92▲ -6.3%Oct 22, 2026 · ThinkSabio Blog

$RCUS Arcus Biosciences: Prices $250M Public Offering at $17.50 per Share…

News
RCUS ▼ -24.1% - Arcus Biosciences, Inc.
CP $18.03▲ -24.1%Oct 22, 2026 · ThinkSabio Blog

$RCUS - Arcus Biosciences Announces Pricing of $250 Million Public Offering of Common Stock…

News
RCUS ▼ -23.1% - Arcus Biosciences, Inc.
CP $18.26▲ -23.1%Oct 21, 2026 · ThinkSabio Blog

$RCUS - Arcus Biosciences Announces Commencement of Public Offering of Common Stock…

News
RCUS ▼ -25.9% - Arcus Biosciences, Inc.
CP $17.61▲ -25.9%Oct 21, 2026 · ThinkSabio Blog

$RCUS Arcus Biosciences Announces Commencement of Public Offering of Common Stock…

News
RCUS ▼ -7.0% - Arcus Biosciences, Inc.
CP $20.58▲ -7.0%Oct 20, 2026 · ThinkSabio Blog

$RCUS down pm RCUS Arcus Biosciences: Shares Fall 12.3% Following Updated Casdatifan Kidney Cancer Data ? • Heavily pretreated patients achieved media…

News
RCUS ▼ -14.1% - Arcus Biosciences, Inc.
CP $19.01▲ -14.1%Oct 20, 2026 · ThinkSabio Blog

$RCUS - Arcus Presents New Data from ARC-20 that Demonstrate the Opportunity for Casdatifan to Become a Foundational Treatment Across All Lines of The…

News
RCUS ▲ +2.5% - Arcus Biosciences, Inc.
CP $24.41▲ +2.5%Oct 10, 2026 · ThinkSabio Blog

$RCUS - Arcus Biosciences Announces New Employment Inducement Grants…

News
RCUS ▼ -5.2% - Arcus Biosciences, Inc.
CP $25.06▲ -5.2%Sep 24, 2026 · ThinkSabio Blog

$RCUS - Arcus Biosciences Announces New Employment Inducement Grants…

News
RCUS ▼ -0.0% - Arcus Biosciences, Inc.
CP $25.95▲ -0.0%Sep 22, 2026 · ThinkSabio Blog

$RCUS - Arcus Biosciences to Host Investor Event Featuring New Data for Casdatifan as a Treatment for Kidney Cancer Across Multiple Lines of Therapy…

News
RCUS ▼ -2.0% - Arcus Biosciences, Inc.
CP $28.49▲ -2.0%Sep 9, 2026 · ThinkSabio Blog

$RCUS - Arcus Biosciences Announces New Employment Inducement Grants…